References
- T.J.KeyP.K.VerkasaloE.BanksEpidemiology of breast cancerLancet Oncol232001133140
- R.SiegelJ.MaZ.ZouA.JemalCancer statistics, 2014CA Cancer J Clin6412014929
- A.JemalF.BrayM.M.CenterJ.FerlayE.WardD.FormanGlobal cancer statisticsCA A Cancer J Clin6120116990
- GLOBOCAN 2012, IARC–18.4.2014, (accessed on April 18, 2014) Available online: http://globocan.iarc.fr/Pages/summary_table_site_prev_sel.aspx.
- Elatar I. Cancer Registration, NCI Egypt, 2001. National Cancer Institute; Cairo, Egypt: 2002, (accessed on April 18, 2014). Available online: http://www.nci.edu.eg/Journal/nci2001%20.pdf.
- S.OmarH.KhaledR.GaafarA.R.ZekryS.EissaO.el-KhatibBreast cancer in Egypt: a review of disease presentation and detection strategiesEast Mediterr Health J92003448463
- Early Breast Cancer Trialists’ Collaborative GroupEffects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsLancet365200516871717
- Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)M.ClarkeA.S.CoatesS.C.DarbyC.DaviesR.D.GelberAdjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trialsLancet37120082940
- C.J.PooleH.M.EarlL.HillerJ.A.DunnS.BathersR.J.GrieveEpirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancerN Engl J Med355200618511862
- L.BertelsenL.BernsteinJ.H.OlsenL.MellemkjærR.W.HaileC.F.LynchEffect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women’s Environment, Cancer and Radiation Epidemiology StudyJ Natl Cancer Inst10020083239
- B.F.ColeR.D.GelberS.GelberA.S.CoatesA.GoldhirschPolychemotherapy for early breast cancer: an overview of the randomized clinical trials with quality-adjusted survival analysisLancet3582001277285
- W.M.LeeDrug-induced hepatotoxicityN Engl J Med3492003474485
- D.A.AubreyMassive hepatic necrosis after cyclophosphamideBr Med J31970588 (Correspondence)
- L.S.SnyderR.I.HeighM.L.AndersonCyclophosphamide-induced hepatotoxicity in a patient with Wegener’s granulomatosisMayo Clin Proc68199312031209
- P.D.KingM.C.PerryHepatotoxicity of chemotherapyOncologist62001162176
- S.C.PiscitelliK.A.RodvoldD.A.RushingD.A.TewksburyPharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancerClin Pharmacol Ther531993555564
- J.R.BatemanR.P.PughF.R.CassidyG.J.MarshallL.E.Irwin5-Fluorouracil given once weekly: comparison of intravenous and oral administrationCancer281971907
- D.S.PrattM.M.KaplanEvaluation of abnormal liver-enzyme results in asymptomatic patientsN Engl J Med342200012661279
- Hepatitis C Fact sheet No 164 (Updated April 2014), (accessed on April 18, 2014). Available online http://www.who.int/mediacentre/factsheets/fs164/en/index.html.
- O.G.PybusA.J.DrummondT.NakanoB.H.RobertsonA.RambautThe epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approachMol Biol Evol2032003381387
- A.CraxìG.LaffiA.L.ZignegoHepatitis C virus (HCV) infection: a systemic diseaseMol Aspects Med29220088595
- C.ColinD.LanoirS.TouzetL.Meyaud-KraemerF.BaillyC.Trepo HEPATIS Group Sensitivity and specificity of third generation hepatitis C virus antibody detection assays: an analysis of the literatureJ Viral Hepat820018795
- Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 pdf, (accessed on June 28, 2014). Available online, http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf.
- R.D.MostellerSimplified calculation of body-surface areaN Engl J Med317198710981106
- V.NoronhaD.TiedmanE.ChuGuidelines for chemotherapy and dose modificationV.T.DeVitaChuPhysicians cancer chemotherapy manual2007Jones and BartletUSA379391
- W.M.HryniukM.GoodyearThe calculation of received dose intensityJ Clin Oncol8199019351937
- N.K.AroraD.H.GustafsonR.P.HawkinsF.McTavishD.F.CellaS.PingreeImpact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma. A prospective studyCancer92200112881298
- P.A.GanzK.DesmondB.LeedhamJ.RowlandB.MeyerowitzT.BelinQuality of life in long-term, disease-free survivors of breast cancer: a follow-upJ Natl Cancer Inst9420023949
- T.KawataniT.SuouF.TajimaIncidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignanciesEur J Haematol6720014549
- H.B.El-SeragH.HampelC.YehL.RabeneckExtrahepatic manifestations of hepatitis C among United States male veteransJ Hepatol36200214391444
- F.FallahianS.M.AlavianV.FallahianF.ZamaniImpact of immunosuppression and chemotherapy on reactivation of Viral hepatitisSaudi J Kidney Dis Transplant212010621627
- H.A.TorresM.DavilaReactivation of hepatitis B virus and hepatitis C virus in patients with cancerNat Rev Clin Oncol92012156166
- Y.FouadM.MakhloufH.KhalafZ.MostafaA.Abdel RaheemW.MeneasiIs irritable bowel syndrome associated with chronic hepatitis C?J Gastroenterol Hepatol25201012851288
- P.MorrowJ.TarrandS.TaylorS.KauR.TheriaultG.HortobagyiEffects of chronic hepatitis C infection on the treatment of breast cancer patientsAnn Oncol21201012331236